D-0868-2020 Class III Terminated

Recalled by AAA Pharmaceutical, Inc. — Lumberton, NJ

FDA drug recall D-0868-2020 was initiated by AAA Pharmaceutical, Inc. on Feb 14, 2020 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date. The recall status is terminated (terminated May 5, 2023). Affected quantity: 3456 Bottles.

Recall details

Product Type
Drugs
Report Date
Mar 11, 2020
Initiation Date
Feb 14, 2020
Termination Date
May 5, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3456 Bottles

Product description

Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor Allergies, 24 Hour, a) 30 tablets per bottle, NDC 53943-192-04, UPC Code 0-93351-03069-7; b) 45 tablets per bottle, NDC 53943-192-06, UPC Code 0-93351-03070-3, Distributed by: Drug Mart -Food Fair, 211 Commerce Drive, Medina, OH 44256.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date.

Distribution pattern

Ohio

Code information

Lot #s: a) P138855, Exp. 05/30/2022; b) P138856, Exp. 05/30/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0868-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AAA Pharmaceutical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0868-2020. Report a data issue: hello@regdatalab.com.